XML 11 R17.htm IDEA: XBRL DOCUMENT
v3.20.1

Employee Benefit and Deferred Compensation Plans | 3 Months Ended
--- | ---
Mar. 31, 2020
Retirement Benefits [Abstract] |
Employee Benefit and Deferred Compensation Plans | Employee Benefit and Deferred Compensation Plans (In Thousands, Except Share Data) Pension and Post-retirement Medical Plans The Company sponsors a noncontributory defined benefit pension plan, under which participation and benefit accruals ceased as of December 31, 1996 and it provides retiree medical benefits, consisting of the opportunity to purchase coverage at subsidized rates under the Company’s group medical plan. Information related to the defined benefit pension plan maintained by Renasant Bank (“Pension Benefits”) and to the post-retirement health and life plan (“Other Benefits”) as of the dates presented is as follows:
| Pension Benefits |  | Other Benefits
| Three Months Ended |  | Three Months Ended
| March 31, |  | March 31,
| 2020 |  | 2019 |  | 2020 |  | 2019
Service cost | $ | — |  |  | $ | — |  |  | $ | 2 |  |  | $ | 2 |
Interest cost | 242 |  |  | 273 |  |  | 5 |  |  | 8 |
Expected return on plan assets | (413 | ) |  | (363 | ) |  | — |  |  | — |
Recognized actuarial loss (gain) | 79 |  |  | 86 |  |  | (18 | ) |  | (14 | )
Net periodic benefit return | $ | (92 | ) |  | $ | (4 | ) |  | $ | (11 | ) |  | $ | (4 | )
Incentive Compensation Plans The Company maintains a long-term equity compensation plan that provides for the grant of stock options and the award of restricted stock. There were no stock options granted, nor compensation expense associated with options recorded, during the three months ended March 31, 2020 or 2019. The following table summarizes information about options outstanding, exercised and forfeited as of and for the three months ended March 31, 2020:
|  | Shares |  | Weighted Average Exercise Price
Options outstanding at beginning of period |  | 29,250 |  |  | $ | 15.86 |
Granted |  | — |  |  | — |
Exercised |  | — |  |  | — |
Forfeited |  | — |  |  | — |
Options outstanding at end of period |  | 29,250 |  |  | $ | 15.86 |
The Company also awards performance-based restricted stock to executives and other officers and employees and time-based restricted stock to non-employee directors, executives, and other officers and employees. The following table summarizes the changes in restricted stock as of and for the three months ended March 31, 2020:
|  | Performance-Based Restricted Stock |  | Weighted Average Grant-Date Fair Value |  | Time- Based Restricted Stock |  | Weighted Average Grant-Date Fair Value
Nonvested at beginning of period |  | 115,725 |  |  | $ | 34.00 |  |  | 500,932 |  |  | $ | 36.34 |
Awarded |  | 81,423 |  |  | 35.42 |  |  | 210,893 |  |  | 35.42 |
Vested |  | — |  |  | — |  |  | (83,740 | ) |  | 39.71 |
Cancelled |  | (2,233 | ) |  | 33.70 |  |  | (22,427 | ) |  | 37.43 |
Nonvested at end of period |  | 194,915 |  |  | $ | 34.60 |  |  | 605,658 |  |  | $ | 35.51 |
During the three months ended March 31, 2020, the Company reissued 104,902 shares from treasury in connection with the exercise of stock options and awards of restricted stock. The Company recorded total stock-based compensation expense of $2,750 and $2,637 for the three months ended March 31, 2020 and 2019, respectively.

X
- Definition The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 712 -URI http://asc.fasb.org/topic&trid=2197446 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 710 -URI http://asc.fasb.org/topic&trid=2127225 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 715 -URI http://asc.fasb.org/topic&trid=2235017 + Details
Name: | us-gaap_CompensationAndEmployeeBenefitPlansTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CompensationAndRetirementDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration